Two experiments evaluated prebreeding target BW or progestin exposure for heifers developed lighter than traditional recommendations. Experiment 1 evaluated the effects of the system on heifer performance through subsequent calving and rebreeding over 3 yr. Heifers (229 kg) were assigned randomly to be developed to 55% of mature BW (299 kg) before a 45-d breeding season (intensive, INT; n = 119) or 50% of mature BW (272 kg) before a 60-d breeding season (relaxed, RLX; n = 142). Prebreeding and pregnancy diagnosis BW were greater (P 0.15) between systems. Cost per pregnant 2-yr-old cow was less for the RLX than the INT heifer development system. Of heifers that failed to become pregnant, a greater proportion (P = 0.07) of heifers in the RLX than in the INT system were prepubertal when the breeding season began. Therefore, a second 2-yr experiment evaluated melengestrol acetate (MGA, 0.5 mg/d) as a means of hastening puberty in heifers developed to 50% of mature BW. Heifers were assigned randomly to the control (n = 103) or MGA (n = 81) treatment for 14 d and were placed with bulls 13 d later for 45 d. Prebreeding and pregnancy diagnosis BW were similar (280 and 380 kg, respectively; P > 0.10) for heifers in the control and MGA treatments. The proportion of heifers pubertal before breeding (74%), pregnancy rate (90%), calving date, calf weaning weight, and second breeding season pregnancy rate (92%) were similar (P > 0.10) between treatments. Developing heifers to 50 or 55% of mature BW resulted in similar overall pregnancy rates, and supplementing the diets of heifers developed to 50% of mature BW with MGA before breeding did not improve reproductive performance.
Forage proteins are degraded rapidly by rumen microorganisms and therefore supply relatively small quantities of undegraded intake protein (UIP). Growing cattle with high metabolizable protein requirements and lactating beef and dairy cows respond to UIP supplementation when fed high-forage diets, even though degradable intake protein (DIP) is adequate. This observation suggests that an accurate estimate of forage UIP is needed to establish optimal supplementation conditions. Microbial protein must be quantitated in duodenal or in situ residue samples to accurately measure forage UIP. Purines commonly are used as a microbial protein marker. Recent reports suggested that the original purine procedure generates interfering compounds that reduce estimates of microbial protein. Reanalysis of samples with a modified purine procedure yielded three to four times more purines in both duodenal samples and NDF residue incubated in situ. An alternative in situ procedure removes the microorganisms by refluxing with neutral detergent after ruminal incubation. This alternative correlates highly to the purine-corrected in situ procedure, and it is less
Sporadic corticobasal syndrome (CBS) has been associated with diverse pathological substrates, but frontotemporal lobar degeneration with TDP-43 immunoreactive inclusions (FTLD-TDP) has only been linked to CBS among progranulin mutation carriers. We report the clinical, neuropsychological, imaging, genetic, and neuropathological features of GS, a patient with sporadic corticobasal syndrome. Genetic testing revealed no mutations in the microtubule associated protein tau (MAPT) or progranulin (PGRN) genes, but GS proved homozygous for the T allele of the rs5848 PGRN variant. Autopsy showed ubiquitin and TDP-43 pathology most similar to a pattern previously associated with PGRN mutation carriers. These findings confirm that FTLD-TDP should be included in the pathological differential diagnosis for sporadic CBS.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.